Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 25, 2016 - Issue 4
Submit an article Journal homepage
618
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pridopidine for the treatment of Huntington’s disease

Kathleen M. ShannonDepartment of Neurological Sciences, Rush Medical College, Rush University Medical Center, Chicago, ILUSACorrespondence[email protected]
Pages 485-492 | Received 07 Dec 2015, Accepted 09 Feb 2016, Published online: 10 Mar 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hassaan Bashir. (2019) Emerging therapies in Huntington’s disease. Expert Review of Neurotherapeutics 19:10, pages 983-995.
Read now
H. Bashir & J. Jankovic. (2018) Treatment options for chorea. Expert Review of Neurotherapeutics 18:1, pages 51-63.
Read now
Thomas Müller. (2017) Investigational agents for the management of Huntington’s disease. Expert Opinion on Investigational Drugs 26:2, pages 175-185.
Read now

Articles from other publishers (5)

Moamen Mostafa Asla, Asmaa Ahmed Nawar, Alaa Abdelsalam, Esraa Elsayed, Marwa Abdelazim Rizk, Mohamed Alaa Hussein & Walaa A. Kamel. (2021) The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta‐Analysis . Movement Disorders Clinical Practice 9:1, pages 20-30.
Crossref
Igor D. Grachev, Philipp M. Meyer, Georg A. Becker, Marcus Bronzel, Doug Marsteller, Gina Pastino, Ole Voges, Laura Rabinovich, Helena Knebel, Franziska Zientek, Michael Rullmann, Bernhard Sattler, Marianne Patt, Thilo Gerhards, Maria Strauss, Andreas Kluge, Peter Brust, Juha-Matti Savola, Mark F. Gordon, Michal Geva, Swen Hesse, Henryk Barthel, Michael R. Hayden & Osama Sabri. (2020) Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study. European Journal of Nuclear Medicine and Molecular Imaging 48:4, pages 1103-1115.
Crossref
Claudia M. Testa & Joseph Jankovic. (2019) Huntington disease: A quarter century of progress since the gene discovery. Journal of the Neurological Sciences 396, pages 52-68.
Crossref
María Teresa Montojo, Miguel Aganzo & Nieves González. (2017) Huntington’s Disease and Diabetes: Chronological Sequence of its Association. Journal of Huntington's Disease 6:3, pages 179-188.
Crossref
Emma M. Coppen & Raymund A. C. Roos. (2016) Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease. Drugs 77:1, pages 29-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.